Literature DB >> 19091605

Failure of serum transforming growth factor-beta (TGF-beta1) as a biomarker of radiographic osteoarthritis at the knee and hip: a cross-sectional analysis in the Johnston County Osteoarthritis Project.

A E Nelson1, F Fang, X A Shi, V B Kraus, T Stabler, J B Renner, T A Schwartz, C G Helmick, J M Jordan.   

Abstract

PURPOSE: To assess associations between serum transforming growth factor-beta (TGF-beta1) and radiographic knee and hip osteoarthritis (rOA) in African American (AA) and White men and women.
METHODS: Baseline data from 330 participants in the Johnston County Osteoarthritis Project were used in the analysis. Radiographs were scored with the Kellgren-Lawrence scale and rOA defined as grade> or =2. Individual radiographic features (IRFs) were rated 0-3. TGF-beta1 was measured using a sandwich enzyme-linked immunosorbent assay (ELISA). General linear models were used to estimate associations between lnTGF-beta1 and rOA presence, laterality or severity, and IRF presence and severity, adjusting for age, gender, race and body mass index. Interactions by race and gender were considered significant at P<0.1.
RESULTS: Mean lnTGF-beta1 levels were higher among AAs compared to Whites, and among women compared to men (P<0.009). Mean lnTGF-beta1 levels were higher in those with knee osteophytes (OST), but this association was not significant after adjustment. There were no other significant differences in mean lnTGF-beta1 levels by presence, laterality, or severity of knee or hip rOA or IRFs. No race or gender interactions were identified, although a borderline significant association between lnTGF-beta1 and knee OST was seen among AAs (P<0.06).
CONCLUSIONS: Although serum TGF-beta1 varied by race and gender and several rOA variables, there were no independent significant associations with presence, laterality, or severity of knee or hip rOA by K-L grade or IRFs, suggesting that serum TGF-beta1 is unlikely to be useful as a stand-alone biomarker in OA studies. A possible association between TGF-beta1 and OST in AAs cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091605      PMCID: PMC2746496          DOI: 10.1016/j.joca.2008.11.010

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  15 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

Review 2.  Do biochemical markers have a role in osteoarthritis diagnosis and treatment?

Authors:  Virginia B Kraus
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-02       Impact factor: 4.098

3.  An analysis of 14 molecular markers for monitoring osteoarthritis. Relationship of the markers to clinical end-points.

Authors:  I G Otterness; E Weiner; A C Swindell; R O Zimmerer; M Ionescu; A R Poole
Journal:  Osteoarthritis Cartilage       Date:  2001-04       Impact factor: 6.576

4.  TGF-beta1 as a prognostic factor in the process of early osteoarthrosis in the rabbit knee.

Authors:  A Fahlgren; B Andersson; K Messner
Journal:  Osteoarthritis Cartilage       Date:  2001-04       Impact factor: 6.576

5.  Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project.

Authors:  Joanne M Jordan; Charles G Helmick; Jordan B Renner; Gheorghe Luta; Anca D Dragomir; Janice Woodard; Fang Fang; Todd A Schwartz; Lauren M Abbate; Leigh F Callahan; William D Kalsbeek; Marc C Hochberg
Journal:  J Rheumatol       Date:  2007-01       Impact factor: 4.666

Review 6.  Transforming growth factor-beta1 to the bone.

Authors:  Katrien Janssens; Peter ten Dijke; Sophie Janssens; Wim Van Hul
Journal:  Endocr Rev       Date:  2005-05-18       Impact factor: 19.871

7.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

Review 8.  Use of biochemical markers to study and follow patients with osteoarthritis.

Authors:  Patrick Garnero
Journal:  Curr Rheumatol Rep       Date:  2006-02       Impact factor: 4.592

Review 9.  The impact of arthritis in rural populations.

Authors:  J M Jordan; G F Linder; J B Renner; J G Fryer
Journal:  Arthritis Care Res       Date:  1995-12

10.  Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies.

Authors:  J F Schlaak; I Pfers; K H Meyer Zum Büschenfelde; E Märker-Hermann
Journal:  Clin Exp Rheumatol       Date:  1996 Mar-Apr       Impact factor: 4.473

View more
  10 in total

Review 1.  Novel opportunities for computational biology and sociology in drug discovery.

Authors:  Lixia Yao; James A Evans; Andrey Rzhetsky
Journal:  Trends Biotechnol       Date:  2010-04       Impact factor: 19.536

Review 2.  What is the utility of biomarkers for assessing the pathophysiology of hip osteoarthritis? A systematic review.

Authors:  Jeffrey J Nepple; Kayla M Thomason; Tonya W An; Marcie Harris-Hayes; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2015-05       Impact factor: 4.176

3.  Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients.

Authors:  Sittisak Honsawek; Aree Tanavalee; Pongsak Yuktanandana; Srihatach Ngarmukos; Natthaphon Saetan; Saran Tantavisut
Journal:  BMC Musculoskelet Disord       Date:  2010-11-10       Impact factor: 2.362

Review 4.  New developments in osteoarthritis. Sex differences in magnetic resonance imaging-based biomarkers and in those of joint metabolism.

Authors:  Mehrnaz Maleki-Fischbach; Joanne M Jordan
Journal:  Arthritis Res Ther       Date:  2010-07-30       Impact factor: 5.156

Review 5.  Novel opportunities for computational biology and sociology in drug discovery.

Authors:  Lixia Yao; James A Evans; Andrey Rzhetsky
Journal:  Trends Biotechnol       Date:  2009-08-10       Impact factor: 19.536

6.  Serum levels of the bone turnover markers dickkopf-1, osteoprotegerin, and TNF-α in knee osteoarthritis patients.

Authors:  Sicong Min; Chao Wang; Wanli Lu; Zhihong Xu; Dongquan Shi; Dongyang Chen; Huajian Teng; Qing Jiang
Journal:  Clin Rheumatol       Date:  2017-07-04       Impact factor: 2.980

7.  Anticytokine therapy for osteoarthritis: evidence to date.

Authors:  Charles J Malemud
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

8.  Serum transforming growth factor-beta 1 is not a robust biomarker of incident and progressive radiographic osteoarthritis at the hip and knee: the Johnston County Osteoarthritis Project.

Authors:  A E Nelson; Y M Golightly; V B Kraus; T Stabler; J B Renner; C G Helmick; J M Jordan
Journal:  Osteoarthritis Cartilage       Date:  2010-02-17       Impact factor: 6.576

9.  Increase in Free and Total Plasma TGF-β1 Following Physical Activity.

Authors:  Ashley J Han; Louie C Alexander; Janet L Huebner; Alexander B Reed; Virginia B Kraus
Journal:  Cartilage       Date:  2020-04-27       Impact factor: 3.117

10.  Immune response and innervation signatures in aseptic hip implant loosening.

Authors:  Daniel M Vasconcelos; Manuel Ribeiro-da-Silva; António Mateus; Cecília Juliana Alves; Gil Costa Machado; Joana Machado-Santos; Diogo Paramos-de-Carvalho; Inês S Alencastre; Rui Henrique; Gilberto Costa; Mário A Barbosa; Meriem Lamghari
Journal:  J Transl Med       Date:  2016-07-07       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.